263 135

Cited 11 times in

Metabolic Pathway Signatures Associated with Urinary Metabolite Biomarkers Differentiate Bladder Cancer Patients from Healthy Controls.

 Won Tae Kim  ;  Seok Joong Yun  ;  Chunri Yan  ;  Pildu Jeong  ;  Ye Hwan Kim  ;  Il-Seok Lee  ;  Ho-Won Kang  ;  Sunghyouk Park  ;  Sung-Kwon Moon  ;  Yung-Hyun Choi  ;  Young Deuk Choi  ;  Isaac Yi Kim  ;  Jayoung Kim  ;  Wun-Jae Kim 
 YONSEI MEDICAL JOURNAL, Vol.57(4) : 865-871, 2016 
Journal Title
Issue Date
Aged ; Biomarkers/metabolism ; Carcinoma, Transitional Cell/genetics ; Carcinoma, Transitional Cell/metabolism* ; Carcinoma, Transitional Cell/pathology ; Carnitine/analogs & derivatives* ; Carnitine/genetics ; Carnitine/metabolism ; Case-Control Studies ; Female ; Humans ; Male ; Metabolic Networks and Pathways/physiology* ; Middle Aged ; RNA, Messenger/metabolism ; Real-Time Polymerase Chain Reaction ; Urinary Bladder Neoplasms/genetics ; Urinary Bladder Neoplasms/metabolism* ; Urinary Bladder Neoplasms/pathology
Bladder cancer ; diagnostic marker ; gene expression ; qRT-PCR ; urine metabolites
PURPOSE: Our previous high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry study identified bladder cancer (BCA)-specific urine metabolites, including carnitine, acylcarnitines, and melatonin. The objective of the current study was to determine which metabolic pathways are perturbed in BCA, based on our previously identified urinary metabolome. MATERIALS AND METHODS: A total of 135 primary BCA samples and 26 control tissue samples from healthy volunteers were analyzed. The association between specific urinary metabolites and their related encoding genes was analyzed. RESULTS: Significant alterations in the carnitine-acylcarnitine and tryptophan metabolic pathways were detected in urine specimens from BCA patients compared to those of healthy controls. The expression of eight genes involved in the carnitine-acylcarnitine metabolic pathway (CPT1A, CPT1B, CPT1C, CPT2, SLC25A20, and CRAT) or tryptophan metabolism (TPH1 and IDO1) was assessed by RT-PCR in our BCA cohort (n=135). CPT1B, CPT1C, SLC25A20, CRAT, TPH1, and IOD1 were significantly downregulated in tumor tissues compared to normal bladder tissues (p<0.05 all) of patients with non-muscle invasive BCA, whereas CPT1B, CPT1C, CRAT, and TPH1 were downregulated in those with muscle invasive BCA (p<0.05), with no changes in IDO1 expression. CONCLUSION: Alterations in the expression of genes associated with the carnitine-acylcarnitine and tryptophan metabolic pathways, which were the most perturbed pathways in BCA, were determined.
Files in This Item:
T201601940.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Urology (비뇨의학교실) > 1. Journal Papers
Yonsei Authors
Choi, Young Deuk(최영득) ORCID logo https://orcid.org/0000-0002-8545-5797
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.